Bladder Cancer
Development of a Multiplex Immuno-Oncology Biomarker and Digital Pathology Workflow for Assessment of Urothelial Carcinoma - Beyond the Abstract
February 1, 2022
Oncofid-P-B for High Risk NMIBC: Do We Really Need a Phase III? Yes, We Do - Beyond the Abstract
January 18, 2022
Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States - Beyond the Abstract
November 15, 2021
Role of Local Therapy in Clinical Node-Positive Bladder Cancer - Beyond the Abstract
November 8, 2021
Association of Age with Response to Preoperative Chemotherapy in Patients with Muscle-Invasive Bladder Cancer - Beyond the Abstract
November 2, 2021